Open AccessDemographic and Epidemiological Characteristics Associated With Reduced Antimicrobial Susceptibility to Neisseria gonorrhoeae in the United States, Strengthening the US Response to Resistant Gonorrhea, 2018 to 2019
Author(s) -
Karen E. Gieseker,
E Learner,
Kerry Mauk,
Lindley A. Barbee,
Candice J McNeil,
Gerald L. Hasty,
Jamie M Black,
Kimberly Johnson,
Trang Nguyen,
Dhana Shrestha,
Cau D. Pham,
Sancta St. Cyr,
Karen Schlanger,
Robert D. Kirkcaldy
Publication year - 2021
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0000000000001541
Subject(s) - cefixime , medicine , gonorrhea , azithromycin , neisseria gonorrhoeae , ceftriaxone , epidemiology , sexually transmitted disease , antimicrobial , antibiotics , syphilis , microbiology and biotechnology , immunology , biology , human immunodeficiency virus (hiv)
Jurisdictions participating in Strengthening the US Response to Resistant Gonorrhea (SURRG) implemented specimen collection for culture and antimicrobial susceptibility testing from a sample of persons of all genders (at multiple anatomic sites) attending sexually transmitted disease clinics and community clinics. We describe the percentage and characteristics of patients whose isolates demonstrated reduced susceptibility (RS) to azithromycin, ceftriaxone, or cefixime.